Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
72.01
+1.12 (1.58%)
At close: Jul 10, 2025, 4:00 PM
71.05
-0.96 (-1.33%)
Pre-market: Jul 11, 2025, 7:00 AM EDT

Corcept Therapeutics Market Cap

Corcept Therapeutics has a market cap or net worth of $7.64 billion as of July 11, 2025. Its market cap has increased by 139.77% in one year.

Market Cap
7.64B
Enterprise Value
7.07B
1-Year Change
139.77%
Ranking
Category
Stock Price
$72.01

Market Cap Chart

Since April 14, 2004, Corcept Therapeutics's market cap has increased from $283.00M to $7.64B, an increase of 2,598.33%. That is a compound annual growth rate of 16.77%.

History

DateMarket Cap% Change
Jul 10, 20257.64B44.64%
Dec 31, 20245.28B57.69%
Dec 29, 20233.35B53.13%
Dec 30, 20222.19B-4.35%
Dec 31, 20212.29B-24.78%
Dec 31, 20203.04B119.78%
Dec 31, 20191.38B-10.36%
Dec 31, 20181.54B-25.15%
Dec 29, 20172.06B155.69%
Dec 30, 2016806.10M48.81%
Dec 31, 2015541.70M78.43%
Dec 31, 2014303.60M-5.24%
Dec 31, 2013320.40M124.53%
Dec 31, 2012142.70M-50.47%
Dec 30, 2011288.10M3.11%
Dec 31, 2010279.40M60.85%
Dec 31, 2009173.70M248.10%
Dec 31, 200849.90M-59.17%
Dec 31, 2007122.20M336.43%
Dec 29, 200628.00M-66.22%
Dec 30, 200582.90M-41.54%
Dec 31, 2004141.80M-49.89%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 698.13B
Johnson & Johnson 374.84B
AbbVie 335.21B
Novo Nordisk 313.36B
UnitedHealth Group 279.13B
Novartis AG 240.15B
Abbott Laboratories 232.02B
AstraZeneca 217.48B
Market Cap Rankings